Evaluation of a method for the simultaneous detection of multiple tumor markers using a multiplex suspension bead array

Clinical Biochemistry

Volumn 45, Issue 16-17, 2012, Pages 1394-1398

  Wang, Yajie ^a,b   Fang, Fang ^a   Shi, Congning ^a   Zhang, Xulong ^c   Liu, Li ^a   Li, Jiutong ^d   Zhou, Xuelei ^d   Yao, Jianer ^d   Kang, Xixiong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Medicine for Cerebrovascular Diseases   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d Shanghai Tellgen Life Science Co Ltd   (China)

Author keywords

Multiplex suspension bead array; Tumor marker

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 242 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CYTOKERATIN 19 FRAGMENT; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ACCURACY; ARTICLE; BIOASSAY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MULTIPLEX SUSPENSION BEAD ARRAY; NEOPLASM; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; SENSITIVITY AND SPECIFICITY;

CASE-CONTROL STUDIES; HUMANS; MICROSPHERES; NEOPLASMS; PROTEIN ARRAY ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84868302316     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.07.087     Document Type: Article

References (13)

1. Hammond M., Taube S. Issues and barriers to development of clinically useful tumor markers: a development pathway proposal. Semin Oncol 2002, 29:213-221.
2. Kilpatrick E.S., Lind M.J. Appropriate requesting of serum tumour markers. BMJ 2009, 339:b3111.
3. Negm R.S., Verma M., Srivastava S. The promise of biomarkers in cancer screening and detection. Trends Mol Med 2002, 8:288-293.
4. Martins T.B. Development of internal controls for the Luminex instrument as part of a multiplex seven-analyte viral respiratory antibody profile. Clin Diagn Lab Immunol 2002, 9:41-45.
5. Carson R.T., Vignali D.A.A. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Methods 1999, 227:41-52.
6. Bellisario R., Colinas R.J., Pass K.A. Simultaneous measurement of antibodies to three HIV-1 antigens in newborn dried blood-spot specimens using a multiplexed microsphere-based immunoassay. Early Hum Dev 2001, 64:21-25.
7. Bellisario R., Colinas R.J., Pass K.A. Simultaneous measurement of thyroxine and thyrotropin from newborn dried blood-spot specimens using a multiplexed fluorescent microsphere immunoassay. Clin Chem 2000, 46:1422-1424.
8. Taylor J., Briley D., Nguyen Q., Long K., Iannone M., Li M., et al. Flow cytometric platform for high-throughput single nucleotide polymorphism analysis. Biotechniques 2001, 30:661-666. 668-669.
9. Samoylova T., Smith B. Flow microsphere immunoassay-based method of virus quantitation. Biotechniques 1999, 27:356-361.
10. Ministry of Health of China National guide to clinical laboratory procedures 2006, Third Edition.
11. Clinical and Laboratory Standards Institute's (CLSI) revised document. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline 2008, (C28-A3). Third Edition.
12. Weber J., Sondak V., Scotland R., Phillip R., Wang F., Rubio V., et al. Granulocyte-macrophage-colony-stimulating factor added to a multipeptide vaccine for resected Stage II melanoma. Cancer 2003, 97:186-200.
13. Jiang B., Snipes-Magaldi L., Dennehy P., Keyserling H., Holman R.C., Bresee J., et al. Cytokines as mediators for or effectors against rotavirus disease in children. Clin Diagn Lab Immunol 2003, 10:995-1001.